Potential supply chain shortages from coronavirus being ‘closely monitored’ by FDA

The FDA is now closely monitoring the medical supply chain in anticipation that the coronavirus (COVID-19) would lead to potential disruptions to supply or shortages of critical medical products in the U.S., according to FDA Commissioner Dr. Stephen M. Hahn.S… [+2247 chars]Source